The SAWC event was an incredible platform for us to … Read More
GelSana Secures NIH SBIR Phase I Funding for Sustained Anti-Inflammatory Cytokine Delivery Hydrogel
GelSana is proud to announce that we have been awarded … Read More
Melissa Krebs Featured in 5280 Magazine, April 2023, “20 Colorado Health Startups That Will Change Your Life”
The 5280 Denver’s Mile High Magazine article discusses the underfunding … Read More
GelSana Selected for CLS FAST Spring 2023 Cohort
GelSana is honored and excited to be selected as one … Read More
GelSana Presents at Destination Startup in Denver, CO, February 2023
GelSana was honored to be one of the companies selected … Read More
Melissa Krebs Interviewed for Academic Female Founders Interview Series by Osage University Partners, December 2022
Melissa Krebs, CEO and Founder of GelSana, was honored to … Read More
GelSana Attends Diabetic Foot Conference (DF Con) in Los Angeles, September 2022!
GelSana attended Diabetic Foot Conference (DF Con) in sunny Los … Read More
GelSana Presents at Colorado BioScience Association Investor and Partnering Conference in Vail, CO, September 2022
GelSana was thrilled to be selected as one of the … Read More
GelSana Wins at the TechConnect World Innovation Conference 2022 Medical Innovation Challenge!
GelSana Therapeutics was selected to participate in the TechConnect World … Read More
GelSana Takes First Place at the 2022 Montfort College of Business Entrepreneurial Challenge
The University of Northern Colorado’s Monfort College of Business has announced the … Read More